Skip to main content

Advertisement

Log in

Effects of short-term DHEA intake on hormonal responses in young recreationally trained athletes: modulation by gender

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Background

Dehydroepiandrosterone (DHEA) figures on the World Anti-Doping Agency list of prohibited substances in sport because it is assumed that athletes expect a significant increase in testosterone through DHEA administration. The literature on the hormonal effects of DHEA intake nevertheless appears to be very scant in healthy young subjects, especially women.

Purpose

We examined the effects of DHEA on adrenal and gonadal hormones, IGF1 and free T3 in healthy young male and female recreationally trained volunteers.

Methods

The study followed a double-blind, randomized-order crossover design. Lean healthy young men (n = 10) and women (n = 11), with all women using oral contraceptives, were treated daily with 100 mg of DHEA and placebo for 4 weeks. DHEA, DHEA-sulfate (DHEA-S), androstenedione, total testosterone (Tes), dihydrotestosterone (DHT), SHBG, estrone, cortisol, IGF1, and free T3 were measured before, in the middle and at the end of each treatment, as were blood glucose, liver transaminases and lipid status.

Results

We observed a significant increase in DHEA, DHEA-S, androstenedione, Tes, DHT, and estrone in both men and women in the middle and at the end of DHEA treatment, but the increase in Tes was more marked in women (p < 0.001) than men (p < 0.05). No changes were found in the other parameters, irrespective of gender.

Conclusion

In young athletes, DHEA administration induces significant blood hormonal changes, some modulated by gender, which can be used as biomarkers of doping.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. World Anti-Doping Agency, A list of prohibited substances and methods (2017). https://www.wada-ama.org

  2. E. Barrett-Connor, Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus. Ann. Intern. Med. 117, 807–811 (1992)

    Article  CAS  Google Scholar 

  3. P.D. Kroboth, F.S. Salek, A.L. Pittenger, T.J. Fabian, R.F. Frye, DHEA and DHEA-S: a review. J. Clin. Pharmacol. 39, 327–348 (1999)

    Article  CAS  Google Scholar 

  4. C. Ohlsson, F. Labrie, E. Barrett-Connor, M.K. Karlsson, O. Ljunggren, L. Vandenput, D. Mellström, A. Tivesten, Low serum levels of dehydroepiandrosterone sulfate predict all-cause and cardiovascular mortality in elderly Swedish men. J. Clin. Endocrinol. Metab. 95, 4406–4414 (2010)

    Article  CAS  Google Scholar 

  5. A.M. Traish, H.P. Kang, F. Saad, A.T. Guay, Dehydroepiandrosterone (DHEA) a precursor steroid or an active hormone in human physiology. J. Sex. Med. 8, 2960–2982 (2011)

    Article  CAS  Google Scholar 

  6. M.C. Jimenez, Q. Sun, M. Schürks, S. Chiuve, F.B. Hu, J.E. Manson, K.M. Rexrode, Low dehydroepiandrosterone sulfate is associated with increased risk of ischemic stroke among women. Stroke 44, 1784–1789 (2013)

    Article  CAS  Google Scholar 

  7. A. Caufriez, R. Leproult, M. L’Hermite-Balériaux, M. Kerkhofs, G. Copinschi, Effects of a 3-week dehydroepiandrosterone administration on sleep, sex steroids and multiple 24-h hormonal profiles in postmenopausal women: a pilot study. Clin. Endocrinol. 79, 716–724 (2013)

    CAS  Google Scholar 

  8. A.M. Kenny, R.S. Boxer, A. Kleppinger, J. Brindisi, R. Feinn, J.A. Burleson, Dehydroepiandrosterone combined with exercise improves muscle strength and physical function in frail older women. J. Am. Geriatr. Soc. 58, 1707–1714 (2010)

    Article  Google Scholar 

  9. P. Merritt, B. Stangl, E. Hirshman, J. Verbalis, Administration of dehydroepiandrosterone (DHEA) increases serum levels of androgens and estrogens but does not enhance short-term memory in post-menopausal women. Brain Res. 5(1483), 54–62 (2012)

    Article  Google Scholar 

  10. A.J. Morales, J.J. Nolan, J.C. Nelson, S.S. Yen, Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J. Clin. Endocrinol. Metab. 78, 1360–1367 (1994)

    CAS  PubMed  Google Scholar 

  11. A.J. Morales, R.H. Haubrich, J.Y. Hwang, H. Asakura, S.S. Yen, The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin. Endocrinol. 49, 421–432 (1998)

    Article  CAS  Google Scholar 

  12. S. Rubino, M. Stomati, C. Bersi, E. Casarosa, M. Luisi, F. Petraglia, A.R. Genazzani, Neuroendocrine effect of a short-term treatment with DHEA in postmenopausal women. Maturitas 28, 251–257 (1998)

    Article  CAS  Google Scholar 

  13. B. Stangl, E. Hirshman, J. Verbalis, Administration of dehydroepiandrosterone (DHEA) enhances visual-spatial performance in postmenopausal women. Behav. Neurosci. 125, 742–752 (2011)

    Article  CAS  Google Scholar 

  14. D. Von Mühlen, G.A. Laughlin, D. Kritz-Silverstein, J. Bergstrom, R. Bettencourt, Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: the DAWN trial. Osteoporos. Int. 19, 699–707 (2008)

    Article  Google Scholar 

  15. S. Yamada, M. Akishita, S. Fukai, S. Ogawa, K. Yamaguchi, J. Matsuyama, K. Kozaki, K. Toba, Y. Ouchi, Effects of dehydroepiandrosterone supplementation on cognitive function and activities of daily living in older women with mild to moderate cognitive impairment. Geriatr. Gerontol. Int. 10, 280–287 (2010)

    Article  Google Scholar 

  16. K.T. Barnhart, E. Freeman, J.A. Grisso, D.J. Rader, M. Sammel, S. Kapoor, J.E. Nestler, The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. J. Clin. Endocrinol. Metab. 84, 3896–3902 (1999)

    CAS  PubMed  Google Scholar 

  17. M.B. Wallace, J. Lim, A. Cutler, L. Bucci, Effects of dehydroepiandrosterone vs androstenedione supplementation in men. Med. Sci. Sports Exerc. 31, 1788–1792 (1999)

    Article  CAS  Google Scholar 

  18. T.C. Liu, C.H. Lin, C.Y. Huang, J.L. Ivy, C.H. Kuo, Effect of acute DHEA administration on free testosterone in middle-aged and young men following high-intensity interval training. Eur. J. Appl. Physiol. 113, 1783–1792 (2013)

    Article  CAS  Google Scholar 

  19. P.D. Kroboth, J.A. Amico, R.A. Stone, M. Folan, R.F. Frye, F.J. Kroboth, K.L. Bigos, T.J. Fabian, A.M. Linares, B.G. Pollock, C. Hakala, Influence of DHEA administration on 24-hour cortisol concentrations. J. Clin. Psychopharmacol. 23, 96–99 (2003)

    Article  CAS  Google Scholar 

  20. J.E. Nestler, C.O. Barlascini, J.N. Clore, W.G. Blackard, Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J. Clin. Endocrinol. Metab. 66, 57–61 (1988)

    Article  CAS  Google Scholar 

  21. G.A. Brown, M.D. Vukovich, R.L. Sharp, T.A. Reifenrath, K.A. Parsons, D.S. King, Effect of oral DHEA on serum testosterone and adaptations to resistance training in young men. J. Appl. Physiol. 1999(87), 2274–2283 (1985)

    Google Scholar 

  22. Y.H. Liao, K.F. Liao, C.L. Kao, C.Y. Chen, C.Y. Huang, W.H. Chang, J.L. Ivy, J.R. Bernard, S.D. Lee, C.H. Kuo, Effect of dehydroepiandrosterone administration on recovery from mix-type exercise training-induced muscle damage. Eur. J. Appl. Physiol. 113, 99–107 (2013)

    Article  CAS  Google Scholar 

  23. S.M. Ostojic, J. Calleja, M. Jourkesh, Effects of short-term dehydroepiandrosterone supplementation on body composition in young athletes. Chin. J. Physiol. 53, 19–25 (2010)

    Article  CAS  Google Scholar 

  24. F. González, C.L. Sia, D.M. Bearson, H.E. Blair, Hyperandrogenism induces a proinflammatory TNFα response to glucose ingestion in a receptor-dependent fashion. J. Clin. Endocrinol. Metab. 99, E848–E854 (2014)

    Article  Google Scholar 

  25. H.J. Coelingh Bennink, Y. Zimmerman, E. Laan, H.M. Termeer, N. Appels, A. Albert, B.C. Fauser, J.H. Thijssen, R.H. van Lunsen, Maintaining physiological testosterone levels by adding dehydroepiandrosterone to combined oral contraceptives: I. Endocrine effects. Contraception 96, 322–329 (2017)

    Article  CAS  Google Scholar 

  26. S.G. Beckham, C.P. Earnest, Four weeks of androstenedione supplementation diminishes the treatment response in middle aged men. Br. J. Sports Med. 37, 212–218 (2003)

    Article  CAS  Google Scholar 

  27. S. Welle, R. Jozefowicz, M. Statt, Failure of dehydroepiandrosterone to influence energy and protein metabolism in humans. J. Clin. Endocrinol. Metab. 71, 1259–1264 (1990)

    Article  CAS  Google Scholar 

  28. K.S. Nair, R.A. Rizza, P. O’Brien, K. Dhatariya, K.R. Short, A. Nehra, J.L. Vittone, G.G. Klee, A. Basu, R. Basu, C. Cobelli, G. Toffolo, C. Dalla Man, D.J. Tindall, L.J. Melton 3rd, G.E. Smith, S. Khosla, M.D. Jensen, DHEA in elderly women and DHEA or testosterone in elderly men. N. Engl. J. Med. 355, 1647–1659 (2006)

    Article  CAS  Google Scholar 

  29. R.S. Boxer, A. Kleppinger, J. Brindisi, R. Feinn, J.A. Burleson, A.M. Kenny, Effects of dehydroepiandrosterone (DHEA) on cardiovascular risk factors in older women with frailty characteristics. Age Ageing 39, 451–458 (2010)

    Article  CAS  Google Scholar 

  30. M. Srinivasan, B.A. Irving, R.L. Frye, P. O’Brien, S.J. Hartman, J.P. McConnell, K.S. Nair, Effects on lipoprotein particles of long-term dehydroepiandrosterone in elderly men and women and testosterone in elderly men. J. Clin. Endocrinol. Metab. 95, 1617–1625 (2010)

    Article  CAS  Google Scholar 

  31. M.L. Kohut, J.R. Thompson, J. Campbell, G.A. Brown, M.D. Vukovich, D.A. Jackson, D.S. King, Ingestion of a dietary supplement containing dehydroepiandrosterone (DHEA) and androstenedione has minimal effect on immune function in middle-aged men. J. Am. Coll. Nutr. 22, 363–371 (2003)

    Article  CAS  Google Scholar 

  32. A. Igwebuike, B.A. Irving, M.L. Bigelow, K.R. Short, J.P. McConnell, K.S. Nair, Lack of dehydroepiandrosterone effect on a combined endurance and resistance exercise program in postmenopausal women. J. Clin. Endocrinol. Metab. 93, 534–538 (2008)

    Article  CAS  Google Scholar 

  33. T. Elraiyah, M.B. Sonbol, Z. Wang, T. Khairalseed, N. Asi, C. Undavalli, M. Nabhan, O. Altayar, L. Prokop, V.M. Montori, M.H. Murad, Clinical review: The benefits and harms of systemic dehydroepiandrosterone (DHEA) in postmenopausal women with normal adrenal function: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 99, 3536–3542 (2014)

    Article  CAS  Google Scholar 

  34. K.K. Dhatariya, L.J. Greenlund, M.L. Bigelow, P. Thapa, A.L. Oberg, G.C. Ford, J.M. Schimke, K.S. Nair, Dehydroepiandrosterone replacement therapy in hypoadrenal women: protein anabolism and skeletal muscle function. Mayo. Clin. Proc. 83, 1218–1225 (2008)

    Article  CAS  Google Scholar 

  35. G. Gebre-Medhin, E.S. Husebye, H. Mallmin, L. Helström, C. Berne, F.A. Karlsson, O. Kämpe, Oral dehydroepiandrosterone (DHEA) replacement therapy in women with Addison’s disease. Clin. Endocrinol. 52, 775–780 (2000)

    Article  CAS  Google Scholar 

  36. J.J. Christiansen, N.H. Andersen, K.E. Sørensen, E.M. Pedersen, P. Bennett, M. Andersen, J.S. Christiansen, J.O. Jørgensen, C.H. Gravholt, Dehydroepiandrosterone substitution in female adrenal failure: no impact on endothelial function and cardiovascular parameters despite normalization of androgen status. Clin. Endocrinol. 66, 426–433 (2007)

    Article  CAS  Google Scholar 

  37. T. Yeung, J. Chai, R. Li, V. Lee, P.C. Ho, E. Ng, A double-blind randomised controlled trial on the effect of dehydroepiandrosterone on ovarian reserve markers, ovarian response and number of oocytes in anticipated normal ovarian responders. BJOG 123, 1097–1105 (2016)

    Article  CAS  Google Scholar 

  38. G. Corona, G. Rastrelli, V.A. Giagulli, A. Sila, A. Sforza, G. Forti, E. Mannucci, M. Maggi, Dehydroepiandrosterone supplementation in elderly men: a meta-analysis study of placebo-controlled trials. J. Clin. Endocrinol. Metab. 98, 3615–3626 (2013)

    Article  CAS  Google Scholar 

  39. F. Labrie, DHEA, important source of sex steroids in men and even more in women. Prog. Brain Res. 182, 97–148 (2010)

    Article  CAS  Google Scholar 

  40. WADA, Technical document reporting and evaluation guidance for testosterone, epitestosterone, T/E ratio and other endogenous steroids: TD2016EAAS, World Anti-Doping Agency (WADA), Montreal (2016).

  41. M. Schönfelder, H. Hofmann, T. Schulz, T. Engl, D. Kemper, B. Mayr, C. Rautenberg, R. Oberhoffer, D. Thieme, Potential detection of low-dose transdermal testosterone administration in blood, urine, and saliva. Drug. Test. Anal. 8, 1186–1196 (2016)

    Article  Google Scholar 

  42. H. Lund, A.H. Snilsberg, T.G. Halvorsen, P. Hemmersbach, L. Reubsaet, Comparison of newly developed immuno-MS method with existing DELFIA(®) immunoassay for human chorionic gonadotropin determination in doping analysis. Bioanalysis 5, 623–630 (2013)

    Article  CAS  Google Scholar 

  43. M. Okano, Y. Nishitani, M. Sato, S. Kageyama, Effectiveness of GH isoform differential immunoassay for detecting rhGH doping on application of various growth factors. Drug Test. Anal. 4, 692–700 (2012).

    Article  CAS  Google Scholar 

  44. S.C. Voss, N. Robinson, M. Alsayrafi, P.C. Bourdon, Y.O. Schumacher, M. Saugy, S. Giraud, The effect of a period of intense exercise on the marker approach to detect growth hormone doping in sports. Drug. Test. Anal. 6, 582–586 (2014)

    Article  CAS  Google Scholar 

  45. P. Fénichel, F. Paris, P. Philibert, S. Hiéronimus, L. Gaspari, J.Y. Kurzenne, P. Chevallier, S. Bermon, N. Chevalier, C. Sultan, Molecular diagnosis of 5α-reductase deficiency in 4 elite young female athletes through hormonal screening for hyperandrogenism. J. Clin. Endocrinol. Metab. 98, E1055–E1059 (2013)

    Article  Google Scholar 

  46. S. Bermon, P.Y. Garnier, A.L. Hirschberg, N. Robinson, S. Giraud, R. Nicoli, N. Baume, M. Saugy, P. Fénichel, S.J. Bruce, H. Henry, G. Dollé, M. Ritzen, Serum androgen levels in elite female athletes. J. Clin. Endocrinol. Metab. 99, 4328–4335 (2014)

    Article  CAS  Google Scholar 

  47. F. Ponzetto, F. Mehl, J. Boccard, N. Baume, S. Rudaz, M. Saugy, R. Nicoli, Longitudinal monitoring of endogenous steroids in human serum by UHPLC-MS/MS as a tool to detect testosterone abuse in sports. Anal. Bioanal. Chem. 408, 705–719 (2016)

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This project was carried out with the support of the World Anti-Doping Agency (WADA) and of the French Anti-Doping Agency (AFLD). The authors wish to express their gratitude to the subjects for their dedicated performance. In addition, we likewise thank Cathy Azulay, Blandine Bedora, Cathy Carmeni, Nathalie Crépin, Noëmie Etes, Dr. Jean Israël, Clotilde Le Tiec, Isabelle Le, Christiane Papelier, and Thierry Poulain for their expert assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Katia Collomp.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interest that would prejudice the impartiality of the reported scientific work.

Ethical approval

All procedures performed in this study were in accordance with the ethical standards of the national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. All individual participants included in the study provided written informed consent according to Institutional Review Board guidelines for the protection of human subjects.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Collomp, K., Buisson, C., Gravisse, N. et al. Effects of short-term DHEA intake on hormonal responses in young recreationally trained athletes: modulation by gender. Endocrine 59, 538–546 (2018). https://doi.org/10.1007/s12020-017-1514-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-017-1514-z

Keywords

Navigation